Skip to content
DNDi Logo
  • DNDi INTERNATIONAL
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT DNDi
    • ABOUT DNDi NORTH AMERICA
    • OUR TEAM
    • BOARD OF DIRECTORS
    • OUR PUBLICATIONS
    • FINANCIALS
    • JOBS
    • Close
  • DISEASES & PROJECTS
  • ADVOCACY
  • MEDIA CENTER
  • DONATE
  • CONTACT
    • Close
  • Home

Media Center

RSS SCIENTIFIC ARTICLES

  • Towards consensus on correct interpretation of protein binding in plasma and other biological matrices for COVID‐19 therapeutic development
  • Outdoor Residual Insecticide Spraying (ODRS), a new approach for the control of the exophilic vectors of human visceral leishmaniasis: Phlebotomus orientalis in East Africa
  • COVID-19: implications for people with Chagas disease

RSS PRESS RELEASES

  • Largest clinical trial in Africa to treat COVID-19 cases before they become severe is launched in 13 countries
  • Thailand’s Prince Mahidol Award honours Dr Bernard Pécoul, Founder of DNDi, for his service to public health
  • COVID-19: first set of specific healthcare recommendations issued for people living with Chagas disease

RSS NEWS

  • Siriraj Institute of Clinical Research and DNDi to collaborate on initiatives to address the gaps in R&D and access to medicines
  • DNDi Board Member awarded title for his leadership in Malaysian COVID-19 response
  • DNDi in India – Highlights from 2019

RSS IN THE MEDIA

  • 13 African countries launch clinical trials to enhance treatment of mild COVID-19 cases
  • Accélération de la pandémie moins rapide, mais le nombre de décès augmente – Le suivi du Covid-19 dans le monde
  • Étude clinique sur le Covid-19 en Afrique : “Le but est d’avoir un médicament pour empêcher une évolution sévère de la maladie”

RSS Scientific Articles

  • Towards consensus on correct interpretation of protein binding in plasma and other biological matrices for COVID‐19 therapeutic development
  • Outdoor Residual Insecticide Spraying (ODRS), a new approach for the control of the exophilic vectors of human visceral leishmaniasis: Phlebotomus orientalis in East Africa
  • COVID-19: implications for people with Chagas disease
  • Domestic Triatoma sanguisuga–human exposure in the South Carolina coastal region

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Subscribe

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website

Donate

Support research for neglected disease treatments by making a gift

Authorize.net Seal

Charity Status

GuideStar Gold Participantnewyork-ac-seal-vertical-black-web

Social Mission Ratio

DNDi social mission ratio 2019

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close